Brother Technology: PEEK is a key application field of hydroquinone, and the company is still in the promotion stage. Brother Technology (002562) said on the interactive platform that the company's hydroquinone products are mainly sold to domestic mainstream acrylic acid producers, and PEEK is a key application field of hydroquinone, and the company is still in the promotion stage; The production capacity of the second phase project of hydroquinone is being released as planned. At present, the company has a production capacity of 20,000 tons of catechol and hydroquinone. Regarding the industrial chain extension plan, the company will carry out relevant work according to the strategic plan and disclose information in time according to the requirements of information disclosure.The net outflow of the main market exceeded 10 billion.Shaanxi Construction Co., Ltd. and others set up a new company in Altay, Xinjiang. The enterprise search APP shows that Altay Construction Engineering Co., Ltd. was established recently, with Li Shibing as the legal representative and a registered capital of 40 million yuan. Its business scope includes: construction project construction; Construction professional work; Construction of cultural relics protection project; Building intelligent system design, etc. Enterprise investigation shows that the company is jointly held by Shaanxi Construction Co., Ltd..
Starting at 2.19 million yuan, the world's most expensive iPhone16ProMax appeared. On December 12, it was reported that Caviar, a luxury goods company in Dubai, once again customized and launched the world's most expensive iPhone 16 Pro Max, decorated with a crown made of 18K pure gold and inlaid with precious gems. The starting price was 301,070 US dollars (currently about 2.189 million yuan).Ordinary people invested in the establishment of a Chinese medicine comprehensive clinic company. The enterprise search APP shows that Yangzhong Ordinary People Chinese Medicine Comprehensive Clinic Co., Ltd. was recently established, with lin li as the legal representative and a registered capital of 100,000 yuan. Its business scope includes: drug retail; Chinese medicine clinic service. Enterprise investigation shows that the company is indirectly wholly owned by ordinary people.Agency: It is expected that the shipment of folding smartphones will continue to decline in 2025. According to the latest report of Counterpoint Research, the year-on-year shipment of folding smartphone displays declined for the first time in the third quarter of 2024, and it is expected that the shipment in 2025 will also continue to decline. The agency expects Apple to enter the market in the second half of 2026. In addition, more multi-fold products are expected to be launched in 2026, and the first slidable notebook computer is expected to be available in 2025.
The Nikkei index rose above 40,000 points, and the US CPI data supported the Fed's interest rate cut expectations. The Japanese stock market climbed with the technology stocks, and the US inflation met expectations, which supported the Fed's interest rate cut expectations this month. After the yen weakened late yesterday, the shares of export enterprises also rose. The Topix index rose 1.2% to 2,783.63 points, and the Nikkei 225 index rose 1.7% to 40,038.02 points. The index rose above 40,000 points for the first time since October 15th.Marubi Co., Ltd. changed its name to Marubi Bio, and Marubi Co., Ltd. officially changed its name to Marubi Bio (603983.SH). This name change has been approved by Shanghai Stock Exchange and announced.Yunnan Baiyao and others set up the equity fund of TCM Big Health Innovation. The enterprise search APP shows that recently, Yunnan TCM Big Health Innovation Equity Investment Fund Partnership (Limited Partnership) was established with a capital contribution of 7 billion yuan, and its business scope includes: engaging in equity investment, investment management, asset management and other activities with private equity funds. Enterprise investigation shows that the enterprise is jointly held by Yunnan Baiyao and BOC International Investment Co., Ltd., a wholly-owned subsidiary of BOC Securities.
Strategy guide
12-13
Strategy guide
12-13
Strategy guide
12-13